Summary of the clinical trials presented in the Annual Scientific Sessions of the American College of Cardiology (Atlanta, United States, March 14-16, 2010);Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Atlanta, Estados Unidos, 14-16 de marzo de 2010)

Revista Espanola de Cardiologia

Volumn 63, Issue 6, 2010, Pages 695-707

  Pérez De Isla, Leopoldo ^a   Bayes Genis, Antoni ^a   Sanchis, Juan ^a   Heras, Magda ^a  

^a Sociedad Española de Cardiología ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETRIXABAN; BLOOD CLOTTING FACTOR 10A; CILOSTAZOL; CLOPIDOGREL; DIGOXIN; DIURETIC AGENT; FENOFIBRATE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; RAPAMYCIN; SIMVASTATIN; VALSARTAN; WARFARIN; ZOTAROLIMUS;

ARTICLE; BALLOON CATHETER; CARDIOLOGY; CARDIOMYOPATHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; CRYOABLATION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; HYPOLIPEMIA; MEDICAL SOCIETY; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; ST SEGMENT ELEVATION; UNITED STATES; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; HEART DISEASE;

CLINICAL TRIALS AS TOPIC; HEART DISEASES; HUMANS;

EID: 77954987267     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70162-7     Document Type: Article

References (30)

1. J. Segovia, J. Bermejo, and F. Alfonso Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (New Orleans, Estados Unidos, 24-27 de marzo de 2007) Rev Esp Cardiol 60 2007 626 638
2. J. Bermejo, J. Segovia, and F. Alfonso Resumen de los ensayos clínicos presentados en las Sesiones Científicas anuales de la American Heart Association 2007 (Orlando, Estados Unidos, 4-7 de noviembre de 2007) Rev Esp Cardiol 61 2008 185 193
3. a Sesión Científica Anual del American College of Cardiology (Chicago, Estados Unidos, 30 de marzo-2 de abril de 2008) Rev Esp Cardiol 61 2008 726 737
4. J. Bermejo, J. Segovia, and F. Alfonso Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (New Orleans, Estados Unidos, 8-12 de noviembre de 2008) Rev Esp Cardiol 62 2009 178 187
5. J. Segovia, J. Bermejo, and F. Alfonso Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales del American College of Cardiology (Orlando, Estados Unidos, 28-31 de marzo de 2009) Rev Esp Cardiol 62 2009 660 669
6. M. Heras, J. Bermejo, J. Segovia, and F. Alfonso Resumen de los ensayos clínicos presentados en las sesiones científicas del Congreso de la Sociedad Europea de Cardiología (Barcelona, España, 29 de agosto-2 de septiembre de 2009) Rev Esp Cardiol 62 2009 1149 1160
7. L. Pérez de Isla, A. Bayes-Genis, J. Sanchis, and M. Heras Resumen de los ensayos clínicos presentados en las Sesiones Científicas Anuales de la American Heart Association (Orlando, Estados Unidos, 14-18 de noviembre de 2009) Rev Esp Cardiol 63 2010 190 199
8. The ACCORD Study Group Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 2010 Mar 14 [publicación electrónica previa]
9. The ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 2010 Mar 14 [publicación electrónica previa].
10. The NAVIGATOR Study Group Effect of nateglinide on the incidence of diabetes and cardiovascular events N Engl J Med 2010 Mar 14 [publicación electrónica previa].
11. The NAVIGATOR Study Group Effect of valsartan on the incidence of diabetes and cardiovascular events N Engl J Med 2010 Mar 14 [publicación electrónica previa].
12. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST elevation acute coronary syndrome: First meta-analysis of 5-year outcomes based on individual patient data (FIR Trial Collaboration) [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/ rapidnewssummaries/summary.asp?SumID=507
13. Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE) [citado 16 Mar 2010]. Disponible en: http://www.cardiosource.com/ clinicaltrials/trial.asp?trialID=1924
14. Endovascular Valve Edge-to-Edge Repair Study II (EVEREST II) [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/clinicaltrials/trial.asp? trialID=1914
15. Radial Artery Grafts Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study (VACABG) [citado 16 Mar 2010]. Disponible en: http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1918
16. R.H. Jones, E.J. Velazquez, R.E. Michler, G. Sopko, J.K. Oh, C.M. O'Connor En representación de los investigadores de STICH Hypothesis 2 Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
17. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation (STOP-AF) [citado 15 Mar 2010]. Disponible en: http://www. cardiosource.com/clinicaltrials/trial.asp?trialID=1922
18. Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA Pilot Study) [citado 15 Mar 2010]. Disponible en: http://www. cardiosource.com/clinicaltrials/trial.asp?trialID=1921
19. I.C. Van Gelder, H.F. Groenveld, H.J.G.M. Crijns, Y.S. Tuininga, J.G.P. Tijssen, A.M. Alings En representación de los investigadores II RACE Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 2010 Mar 15 [publicación electrónica previa].
20. A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation (EXPLORE-Xa) [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/ clinicaltrials/trial.asp?trialID=1913
21. CILostazol-based triple anti-platelet therapy ON Ischemic Complication after drug-eluting stenT implantation (CILON-T) [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1923
22. Long-Term Safety and Efficacy of Stenting versus Coronary-Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: 5-Year Results from the MAINCOMPARE Registry [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/rapidnewssummaries/summary.asp?SumID=506
23. S.J. Park, D.W. Park, Y.H. Kim, S.J. Kang, S.W. Lee, and C.W. Lee Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 2010 Mar 15 [publicación electrónica previa].
24. Intracoronary Stenting and Angiographic Results - Test Efficacy of 3 Limus-Eluting STents (ISAR-TEST-2) [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1759
25. K. Rasmussen, M. Maeng, A. Kaltoft, P. Thayssen, H. Kelbæk, H.H. Tilsted En nombre del grupo de estudio SORT OUT Efficacy and safety of zotarolimus-eluting and sirolimuseluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial Lancet 2010 Mar 15 [publicación electrónica previa]. doi:10.1016/S0140-6736(10) 60208-5.
26. First Report of the PERSEUS Randomized Controlled Trial Comparison of a Novel Platinum-Chromium, Thin-Strut TAXUS Element Stent Versus the TAXUS Express Stent in De Novo Coronary Stenoses [citado 15 Mar 2010]. Disponible en: http://www.cardiosource.com/rapidnewssummaries/summary.asp?SumID=508
27. Comparison of AngioJet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting to Direct Stenting Alone in Patients With Acute Myocardial Infarction (JETSTENT) [citado 16 Mar 2010]. Disponible en: http://www. cardiosource.com/clinicaltrials/trial.asp?trialID=1915
28. Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION): Stent Study [citado 16 Mar 2010]. Disponible en: http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1618
29. H. Kelbaek, L. Thuesen, S. Helqvist, P. Clemmensen, L. Kløvgaard, and A. Kaltoft Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial Circulation 118 2008 1155 1162
30. Paclitaxel-Eluting Stent Versus Conventional Stent in STSegment Elevation Myocardial Infarction (PASSION: 5-Year Follow-Up) [citado 16 Mar 2010]. Disponible en: http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1410